Search

Changhwa J. Cheu

Examiner (ID: 6970)

Most Active Art Unit
1678
Art Unit(s)
1678, 1677, 1641
Total Applications
1728
Issued Applications
1108
Pending Applications
178
Abandoned Applications
490

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 12866362 [patent_doc_number] => 20180180629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-28 [patent_title] => ACTIVATORS OF TonEBP FOR USE FOR HYDRATING SKIN [patent_app_type] => utility [patent_app_number] => 15/831769 [patent_app_country] => US [patent_app_date] => 2017-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3736 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15831769 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/831769
Activators of TonEBP for use for hydrating skin Dec 4, 2017 Issued
Array ( [id] => 15212873 [patent_doc_number] => 20190369123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-05 [patent_title] => ACPA-NEGATIVE RA DIAGNOSTIC MARKER AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 16/485102 [patent_app_country] => US [patent_app_date] => 2017-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5457 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16485102 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/485102
ACPA-NEGATIVE RA DIAGNOSTIC MARKER AND APPLICATION THEREOF Nov 14, 2017 Abandoned
Array ( [id] => 15180855 [patent_doc_number] => 20190361019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-28 [patent_title] => ACPA-NEGATIVE RA DIAGNOSTIC MARKER AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 16/485098 [patent_app_country] => US [patent_app_date] => 2017-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5374 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16485098 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/485098
ACPA-NEGATIVE RA DIAGNOSTIC MARKER AND APPLICATION THEREOF Nov 14, 2017 Abandoned
Array ( [id] => 13053761 [patent_doc_number] => 10048266 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-14 [patent_title] => Diagnostic biomarkers and therapeutic targets for pancreatic cancer [patent_app_type] => utility [patent_app_number] => 15/809555 [patent_app_country] => US [patent_app_date] => 2017-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 20 [patent_no_of_words] => 7466 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15809555 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/809555
Diagnostic biomarkers and therapeutic targets for pancreatic cancer Nov 9, 2017 Issued
Array ( [id] => 12234274 [patent_doc_number] => 20180067138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-08 [patent_title] => 'Lipidomic Biomarkers for Identification of High-Risk Coronary Artery Disease Patients' [patent_app_type] => utility [patent_app_number] => 15/803252 [patent_app_country] => US [patent_app_date] => 2017-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 41235 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15803252 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/803252
Lipidomic biomarkers for identification of high-risk coronary artery disease patients Nov 2, 2017 Issued
Array ( [id] => 14932929 [patent_doc_number] => 20190302102 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-03 [patent_title] => COMBINATION THERAPIES FOR TREATING BIPOLAR DISORDER, AND METHODS FOR USING THE SAME [patent_app_type] => utility [patent_app_number] => 16/346212 [patent_app_country] => US [patent_app_date] => 2017-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23679 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -51 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16346212 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/346212
COMBINATION THERAPIES FOR TREATING BIPOLAR DISORDER, AND METHODS FOR USING THE SAME Oct 25, 2017 Abandoned
Array ( [id] => 14854909 [patent_doc_number] => 10416174 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2019-09-17 [patent_title] => Diagnosis and prognosis for chronic fatigue syndrome [patent_app_type] => utility [patent_app_number] => 15/795134 [patent_app_country] => US [patent_app_date] => 2017-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11977 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15795134 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/795134
Diagnosis and prognosis for chronic fatigue syndrome Oct 25, 2017 Issued
Array ( [id] => 18188565 [patent_doc_number] => 11579141 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-14 [patent_title] => Methods for identifying a non-healing skin wound and for monitoring the healing of a skin wound [patent_app_type] => utility [patent_app_number] => 16/344356 [patent_app_country] => US [patent_app_date] => 2017-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 45 [patent_no_of_words] => 40900 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 933 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16344356 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/344356
Methods for identifying a non-healing skin wound and for monitoring the healing of a skin wound Oct 22, 2017 Issued
Array ( [id] => 12157773 [patent_doc_number] => 20180029034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-01 [patent_title] => 'METHODS FOR CONDUCTING MULTIPLEXED ASSAYS' [patent_app_type] => utility [patent_app_number] => 15/784399 [patent_app_country] => US [patent_app_date] => 2017-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 37359 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15784399 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/784399
Methods for conducting multiplexed assays Oct 15, 2017 Issued
Array ( [id] => 12261735 [patent_doc_number] => 20180080931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-22 [patent_title] => 'REGULATORY BRAIN SPECIFIC CTYOPLASMIC RNAS (BC RNAs) AND METHODS OF USE THEREOF IN DIAGNOSIS AND TREATMENT OF NEUROPSYCHIATRIC LUPUS' [patent_app_type] => utility [patent_app_number] => 15/729034 [patent_app_country] => US [patent_app_date] => 2017-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7850 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15729034 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/729034
Regulatory brain specific ctyoplasmic RNAs (BC RNAs) and methods of use thereof in diagnosis and treatment of neuropsychiatric lupus Oct 9, 2017 Issued
Array ( [id] => 15457349 [patent_doc_number] => 20200041499 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-06 [patent_title] => MULTI-PROTEASE METHOD [patent_app_type] => utility [patent_app_number] => 16/339810 [patent_app_country] => US [patent_app_date] => 2017-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44254 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16339810 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/339810
Multi-protease method Oct 5, 2017 Issued
Array ( [id] => 15150339 [patent_doc_number] => 20190353647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-21 [patent_title] => NOVEL REAL-TIME MULTIPLEXED, MULTI-COLOR BIOLUMINESCENCE RESONANCE ENERGY TRANSFER ASSAY, APPARATUS, AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/339199 [patent_app_country] => US [patent_app_date] => 2017-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16213 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 283 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16339199 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/339199
NOVEL REAL-TIME MULTIPLEXED, MULTI-COLOR BIOLUMINESCENCE RESONANCE ENERGY TRANSFER ASSAY, APPARATUS, AND USES THEREOF Oct 2, 2017 Abandoned
Array ( [id] => 12685321 [patent_doc_number] => 20180120273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-03 [patent_title] => IONIC STRENGTH-MEDIATED PH GRADIENT ION EXCHANGE CHROMATOGRAPHY [patent_app_type] => utility [patent_app_number] => 15/721389 [patent_app_country] => US [patent_app_date] => 2017-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36380 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15721389 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/721389
Ionic strength-mediated pH gradient ion exchange chromatography Sep 28, 2017 Issued
Array ( [id] => 14569467 [patent_doc_number] => 20190212340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-11 [patent_title] => AN ELISA-LIKE ASSAY FOR QUANTIFYING ENZYMATIC ACTIVITIES OF MONO-ADP-RIBOSYLTRANSFERASES [patent_app_type] => utility [patent_app_number] => 16/336074 [patent_app_country] => US [patent_app_date] => 2017-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16113 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16336074 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/336074
AN ELISA-LIKE ASSAY FOR QUANTIFYING ENZYMATIC ACTIVITIES OF MONO-ADP-RIBOSYLTRANSFERASES Sep 26, 2017 Abandoned
Array ( [id] => 18154089 [patent_doc_number] => 11567064 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-01-31 [patent_title] => Method of predicting the likelihood of success of gene therapy [patent_app_type] => utility [patent_app_number] => 16/330362 [patent_app_country] => US [patent_app_date] => 2017-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5140 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16330362 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/330362
Method of predicting the likelihood of success of gene therapy Sep 26, 2017 Issued
Array ( [id] => 15365997 [patent_doc_number] => 20200018763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-16 [patent_title] => METHODS TO ASSESS BINDING AGENT SPECIFICITY [patent_app_type] => utility [patent_app_number] => 16/335774 [patent_app_country] => US [patent_app_date] => 2017-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36029 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -48 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16335774 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/335774
METHODS TO ASSESS BINDING AGENT SPECIFICITY Sep 25, 2017 Abandoned
Array ( [id] => 17098172 [patent_doc_number] => 20210285963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-16 [patent_title] => Inspection Method Enabling Specific Diagnosis of Pathological State of Diabetic Nephropathy at Early Stage [patent_app_type] => utility [patent_app_number] => 16/338729 [patent_app_country] => US [patent_app_date] => 2017-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10780 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16338729 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/338729
Inspection Method Enabling Specific Diagnosis of Pathological State of Diabetic Nephropathy at Early Stage Sep 25, 2017 Abandoned
Array ( [id] => 17621189 [patent_doc_number] => 11340237 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-24 [patent_title] => Metabolite biomarkers for diseases associated with the contact activation system [patent_app_type] => utility [patent_app_number] => 16/333101 [patent_app_country] => US [patent_app_date] => 2017-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 2 [patent_no_of_words] => 15778 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16333101 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/333101
Metabolite biomarkers for diseases associated with the contact activation system Sep 14, 2017 Issued
Array ( [id] => 14749327 [patent_doc_number] => 20190257837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-22 [patent_title] => Nidogen-1 Fragments Assay [patent_app_type] => utility [patent_app_number] => 16/333444 [patent_app_country] => US [patent_app_date] => 2017-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5607 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16333444 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/333444
Nidogen-1 Fragments Assay Sep 12, 2017 Abandoned
Array ( [id] => 16957174 [patent_doc_number] => 11061027 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-07-13 [patent_title] => Materials and methods for evaluating and treating cancer [patent_app_type] => utility [patent_app_number] => 16/334978 [patent_app_country] => US [patent_app_date] => 2017-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 13 [patent_no_of_words] => 7921 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16334978 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/334978
Materials and methods for evaluating and treating cancer Sep 11, 2017 Issued
Menu